AI startup Causaly raises $60M to help drugmakers with preclinical discovery

The AI hype isn’t letting up: Another startup in the preclinical discovery world has reeled in a fresh $60 million, including investment from Johnson & Johnson’s former chair and CEO Alex Gorsky.

London and San Francisco company Causaly disclosed its Series B Thursday morning, saying it…
Click here to view original post